MedRegulus: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedRegulus
Largest movements
- Cash -€10,638
down €10,638 (-54.3%), from €19,591 to €8,953
mainly Trade debts (-€9,395) and Net result for the year (-€9,117)
- Trade debts -€9,395
down €9,395 (-12.9%), from €72,765 to €63,370
- Profit (loss) carried forward -€9,117
down €9,117 (-3.7%), from -€247,396 to -€256,513
- Accrued charges and deferred income +€7,959
up €7,959 (+85.5%), from €9,310 to €17,269
- Gross operating margin +€68,240
up €68,240 (+99.1%), from -€68,828 to -€588
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €19,771 | €9,218 | -€10,553 | -53.4% |
| Current assets | 29/58 | €19,771 | €9,218 | -€10,553 | -53.4% |
| Amounts receivable within one year | 40/41 | €180 | €265 | +€85 | +47.2% |
| Other amounts receivable | 41 | €180 | €265 | +€85 | +47.2% |
| Cash at bank and in hand | 54/58 | €19,591 | €8,953 | -€10,638 | -54.3% |
| Total equity and liabilities | 10/49 | €19,771 | €9,218 | -€10,553 | -53.4% |
| Equity | 10/15 | -€247,395 | -€256,512 | -€9,117 | -3.7% |
| Contributions | 10/11 | €1 | €1 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€247,396 | -€256,513 | -€9,117 | -3.7% |
| Amounts payable | 17/49 | €267,166 | €265,730 | -€1,436 | -0.5% |
| Amounts payable after more than one year | 17 | €185,091 | €185,091 | = | 0.0% |
| Financial debts | 170/4 | €185,091 | €185,091 | = | 0.0% |
| Amounts payable within one year | 42/48 | €72,765 | €63,370 | -€9,395 | -12.9% |
| Trade debts | 44 | €72,765 | €63,370 | -€9,395 | -12.9% |
| Suppliers | 440/4 | €72,765 | €63,370 | -€9,395 | -12.9% |
| Accrued charges and deferred income | 492/3 | €9,310 | €17,269 | +€7,959 | +85.5% |
| Other operating charges | 640/8 | - | €120 | +€120 | |
| Gross operating margin | 9900 | -€68,828 | -€588 | +€68,240 | +99.1% |
| Operating profit (loss) | 9901 | -€68,828 | -€708 | +€68,120 | +99.0% |
| Financial charges | 65/66B | €8,520 | €8,409 | -€111 | -1.3% |
| Recurring financial charges | 65 | €8,520 | €8,409 | -€111 | -1.3% |
| Profit (loss) for the period before taxes | 9903 | -€77,348 | -€9,117 | +€68,231 | +88.2% |
| Profit (loss) for the period | 9904 | -€77,348 | -€9,117 | +€68,231 | +88.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€77,348 | -€9,117 | +€68,231 | +88.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.